Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21412072)

  • 1. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
    Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
    Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
    Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
    Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
    Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
    PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
    West RB
    Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.
    Silveira SM; Villacis RA; Marchi FA; Barros Filho Mde C; Drigo SA; Neto CS; Lopes A; da Cunha IW; Rogatto SR
    PLoS One; 2013; 8(6):e67643. PubMed ID: 23825676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
    Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
    Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas.
    Miettinen M; Sarlomo-Rikala M; Sobin LH; Lasota J
    Am J Surg Pathol; 2000 Feb; 24(2):211-22. PubMed ID: 10680889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
    Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
    Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
    J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases.
    Miettinen M; Kopczynski J; Makhlouf HR; Sarlomo-Rikala M; Gyorffy H; Burke A; Sobin LH; Lasota J
    Am J Surg Pathol; 2003 May; 27(5):625-41. PubMed ID: 12717247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.
    Davidson B; Abeler VM; Hellesylt E; Holth A; Shih IeM; Skeie-Jensen T; Chen L; Yang Y; Wang TL
    Gynecol Oncol; 2013 Feb; 128(2):349-55. PubMed ID: 23178314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
    Carneiro A; Francis P; Bendahl PO; Fernebro J; Akerman M; Fletcher C; Rydholm A; Borg A; Nilbert M
    Lab Invest; 2009 Jun; 89(6):668-75. PubMed ID: 19290004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
    Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
    Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.
    Guled M; Pazzaglia L; Borze I; Mosakhani N; Novello C; Benassi MS; Knuutila S
    Genes Chromosomes Cancer; 2014 Aug; 53(8):693-702. PubMed ID: 24771630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
    Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of MCM2 With Ki67 and p16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas.
    Keyhanian K; Lage JM; Chernetsova E; Sekhon H; Eslami Z; Islam S
    Int J Gynecol Pathol; 2020 Jul; 39(4):354-361. PubMed ID: 32515921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsupervised analysis uncovers changes in histopathologic diagnosis in supervised genomic studies.
    Nykter M; Hunt KK; Pollock RE; El-Naggar AK; Taylor E; Shmulevich I; Yli-Harja O; Zhang W
    Technol Cancer Res Treat; 2006 Apr; 5(2):177-82. PubMed ID: 16551137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.